You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Business & Finance
Perrigo increases quarterly dividend
20 February 2025 -

Perrigo Company plc (NYSE: PRGO), an American-Irish manufacturer of health and wellness products, on Wednesday announced a 5% increase in its quarterly dividend.

The company has increased its quarterly cash dividend to USD0.290 per share, or USD1.16 per share on an annual basis, from USD0.276 per share.

Shareholders of record at 7 March 2025 will receive the dividend on 25 March 2025.

Login
Username:

Password:


Related Headlines

INOVIO's oartner ApolloBio reports positive topline results from Phase 3 trial of VGX-3100

Lilly declares Q2 2026 dividend

Collegium to acquire AZSTARYS from Corium Therapeutics

CVS Health announces quarterly dividend of USD0.665 per share

Convatec launches co-branded eakin freeseal ostomy seal in North America

UHS to acquire Talkspace for USD835m

Abbott announces quarterly dividend

Aptamer Optimer technology integrated into Twist Bioscience TrueAmp Library Preparation Kit

Alvotech reports positive PK study results for AVT80 biosimilar candidate

Inspiration Healthcare secures US purchasing agreement to drive Airon growth

West to sell SmartDose 3.5mL On-Body Delivery System rights to AbbVie for USD112.5m

Citius Pharmaceuticals reports full-year financial results

Sanofi receives FDA complete response letter for tolebrutinib in progressive MS

Abbott announces quarterly common dividend increase

Amgen announces Q1 2026 dividend

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026